Anti-bipolar therapy: mechanism of action of lithium
- PMID: 10208444
- DOI: 10.1038/sj.mp.4000494
Anti-bipolar therapy: mechanism of action of lithium
Abstract
This review introduces the concepts that multiple actions of lithium are critical for its therapeutic effect, and that these complex effects stabilize neuronal activities, support neural plasticity, and provide neuroprotection. Three interacting systems appear most critical. (i) Modulation of neurotransmitters by lithium likely readjusts balances between excitatory and inhibitory activities, and decreased glutamatergic activity may contribute to neuroprotection. (ii) Lithium modulates signals impacting on the cytoskeleton, a dynamic system contributing to neural plasticity, at multiple levels, including glycogen synthase kinase-3beta, cyclic AMP-dependent kinase, and protein kinase C, which may be critical for the neural plasticity involved in mood recovery and stabilization. (iii) Lithium adjusts signaling activities regulating second messengers, transcription factors, and gene expression. The outcome of these effects appears likely to result in limiting the magnitudes of fluctuations in activities, contributing to a stabilizing influence induced by lithium, and neuroprotective effects may be derived from its modulation of gene expression.
Similar articles
-
Overview of the mechanism of action of lithium in the brain: fifty-year update.J Clin Psychiatry. 2000;61 Suppl 9:5-15. J Clin Psychiatry. 2000. PMID: 10826655 Review.
-
[Mechanism of action of lithium: intracellular signaling pathways].Vertex. 2003 Mar-May;14(51):45-52. Vertex. 2003. PMID: 12690409 Review. Spanish.
-
An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.Int J Mol Sci. 2017 Dec 11;18(12):2679. doi: 10.3390/ijms18122679. Int J Mol Sci. 2017. PMID: 29232923 Free PMC article. Review.
-
Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.Acta Psychiatr Scand. 2012 Nov;126(5):332-41. doi: 10.1111/j.1600-0447.2012.01889.x. Epub 2012 Jun 8. Acta Psychiatr Scand. 2012. PMID: 22676371 Free PMC article. Review.
-
Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.J Clin Psychiatry. 1999;60 Suppl 2:27-39; discussion 40-1, 113-6. J Clin Psychiatry. 1999. PMID: 10073385 Review.
Cited by
-
The Genetics of Response to and Side Effects of Lithium Treatment in Bipolar Disorder: Future Research Perspectives.Front Pharmacol. 2021 Mar 25;12:638882. doi: 10.3389/fphar.2021.638882. eCollection 2021. Front Pharmacol. 2021. PMID: 33867988 Free PMC article. Review.
-
Effects of 3,4-methylenedioxypyrovalerone (MDPV) pre-exposure on the aversive effects of MDPV, cocaine and lithium chloride: Implications for abuse vulnerability.Drug Alcohol Depend. 2016 Oct 1;167:121-7. doi: 10.1016/j.drugalcdep.2016.08.008. Epub 2016 Aug 7. Drug Alcohol Depend. 2016. PMID: 27520883 Free PMC article.
-
A critical inquiry into marble-burying as a preclinical screening paradigm of relevance for anxiety and obsessive-compulsive disorder: Mapping the way forward.Cogn Affect Behav Neurosci. 2019 Feb;19(1):1-39. doi: 10.3758/s13415-018-00653-4. Cogn Affect Behav Neurosci. 2019. PMID: 30361863 Review.
-
Hyperactivity, startle reactivity and cell-proliferation deficits are resistant to chronic lithium treatment in adult Nr2e1(frc/frc) mice.Genes Brain Behav. 2010 Oct;9(7):681-94. doi: 10.1111/j.1601-183X.2010.00602.x. Epub 2010 Jun 21. Genes Brain Behav. 2010. PMID: 20497236 Free PMC article.
-
Glycogen synthase kinase-3 in the etiology and treatment of mood disorders.Front Mol Neurosci. 2011 Aug 9;4:16. doi: 10.3389/fnmol.2011.00016. eCollection 2011. Front Mol Neurosci. 2011. PMID: 21886606 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
